279
Views
8
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions

, , , , &
Pages 27-40 | Published online: 27 Apr 2016

References

  • World Health OrganizationGuidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid DependenceGenevaWorld Health Organization: Department of Mental Health, Substance Abuse, World Health Organization, International Narcotics Control Board, United Nations Office on Drugs, and Crime2009
  • RichJDBoutwellAEShieldDCAttitudes and practices regarding the use of methadone in US state and federal prisonsJ Urban Health200582341141915917502
  • Substance Abuse and Mental Health Services AdministrationMental Health Services Administration Results from the 2012 National Survey on Drug Use and Health: Summary of National FindingsRockville, MDSubstance Abuse and Mental Health Services Administration2013 NSDUH Series H-46, HHS Publication No. (SMA) 13-4795; 2013
  • ChandlerRKFletcherBWVolkowNDTreating drug abuse and addiction in the criminal justice system: improving public health and safetyJAMA2009301218319019141766
  • MumolaCJKarbergJCDrug Use and Dependence, State and Federal Prisoners2004Washington, DCDepartment of Justice, Bureau of Justice Statistics NCJ 2135302006
  • NunnAZallerNDickmanSTrimburCNijhawanARichJDMethadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide surveyDrug Alcohol Depend20091051–2838819625142
  • DolanKKhoeiEMBrentariCStevensAPrisons and Drugs: A Global Review of Incarceration, Drug Use and Drug ServicesOxfordBeckley Foundation2007
  • SibbaldBMethadone maintenance expands inside federal prisonsCMAJ200216710115412427715
  • Commission of the European Communities (CEC)Report from the Commission to the European Parliament and the Council on the Implementation of the Council Recommendation of 18 June 2003 on the Prevention and Reduction of Health-Related Harm Associated with Drug DependenceBrusselsCommission of the European Communities2007
  • MøllerLGathererAJürgensRStöverHNikogosianHHealth in Prisons: A WHO Guide to the Essentials in Prison HealthCopenhagenWHO Regional Office Europe2007
  • StallwitzAStoverHThe impact of substitution treatment in prisons – a literature reviewInt J Drug Policy200718646447418061872
  • ZamaniSFarniaMTorknejadAPatterns of drug use and HIV-related risk behaviors among incarcerated people in a prison in IranJ Urban Health201087460361620390391
  • HicksJwebpage on the InternetJailed Heroin Addicts in Maryland Can Get Treatment under New ProgramThe Washington Post2015 Available from: http://www.highbeam.com/doc/1P2-38369234.html?Accessed July 15, 2015
  • MarkTLWoodyGEJudayTKleberHDThe economic costs of heroin addiction in the United StatesDrug Alcohol Depend200161219520611137285
  • KinlockTWGordonMSSchwartzRPFitzgeraldTTO’GradyKEA randomized clinical trial of methadone maintenance for prisoners: results at 12 months post-releaseJ Subst Abuse Treat200937327728519339140
  • GenbergBLAstemborskiJVlahovDKirkGDMehtaSHIncarceration and injection drug use in Baltimore, MarylandAddiction201511071152115925845621
  • BinswangerIABlatchfordPJMuellerSRSternMFMortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009Ann Intern Med2013159959260024189594
  • DoleVPRobinsonJWOrracaJTownsESearcyPCaineEMethadone treatment of randomly selected criminal addictsN Engl J Med196928025137213754890477
  • StöverHMichelsIIDrug use and opioid substitution treatment for prisonersHarm Reduct J201071720642849
  • HedrichDAlvesPFarrellMStöverHMøllerLMayetSThe effectiveness of opioid maintenance treatment in prison settings: a systematic reviewAddiction2012107350151721955033
  • LobmaierPPKunøeNGossopMKatevollTWaalHNaltrexone implants compared to methadone: outcomes six months after prison releaseEur Addict Res201016313914520424458
  • KinlockTWBattjesRJSchwartzRPMTC Project TeamA novel opioid maintenance program for prisoners: report of post-release outcomesAm J Drug Alcohol Abuse200531343345416161728
  • RichJDMcKenzieMLarneySMethadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trialLancet2015386999135035926028120
  • DolanKAShearerJMacDonaldMMattickRPHallWWodakADA randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison systemDrug Alcohol Depend2003721596514563543
  • DolanKAShearerJWhiteBZhouJKaldorJWodakADFour-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infectionAddiction2005100682082815918812
  • MaguraSLeeJDHershbergerJBuprenorphine and methadone maintenance in jail and post-release: a randomized clinical trialDrug Alcohol Depend2009991–322223018930603
  • TomasinoVSwansonAJNolanJShumanMThe key extended entry program (KEEP): a methadone treatment program for opiate-dependent inmatesMt Sinai J Med2001681142011135501
  • MaguraSRosenblumALewisCJosephHThe effectiveness of in-jail methadone maintenanceJ Drug Issues1993237599
  • MarzoJNRotilyMMerouehFMaintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003–06)Addiction200910471233124019426291
  • Favrod-CouneTBaroudiMCasillasAOpioid substitution treatment in pretrial prison detention: a case study from Geneva, SwitzerlandSwiss Med Wkly2013143w1389824186493
  • KinlockTWGordonMSSchwartzRPO’GradyKFitzgeraldTTWilsonMA randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-releaseDrug Alcohol Depend2007912–322022717628351
  • McKenzieMZallerNDickmanSLA randomized trial of methadone initiation prior to release from incarcerationSubst Abus2012331192922263710
  • GordonMSKinlockTWSchwartzRPFitzgeraldTTO’GradyKEVocciFJA randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entryDrug Alcohol Depend2014142334024962326
  • GarciaCACorreaGCHernandez ViverADBuprenorphine-naloxone treatment for pre-release opioid-dependent inmate in Puerto RicoJ Addict Med20071312613221768947
  • ZallerNMcKenzieMFriedmannPDGreenTCMcGowanSRichJDInitiation of buprenorphine during incarceration and retention in treatment upon releaseJ Subst Abuse Treat201345222222623541303
  • LeeJDMcDonaldRGrossmanEOpioid treatment at release from jail using extended-release naltrexone: a pilot proof-of-concept randomized effectiveness trialAddiction201511061008101425703440
  • GordonMSKinlockTWVocciFJFitzgeraldTTMemisogluASilvermanBA phase 4, pilot, open-label study of VIVITROL (Extended-Release Naltrexone XR-NTX) for prisonersJ Subst Abuse Treat201559525826299956
  • GOV.UK [webpage on the Internet]Prison Life2015 Available from: https://www.gov.uk/life-in-prison/healthcare-in-prisonAccessed November 9, 2015
  • WilperAPWoolhandlerSBoydJWThe health and health care of US prisoners: results of a nationwide surveyAm J Public Health200999466667219150898
  • BoucherRThe case for methadone maintenance treatment in prisonsVt L Rev200327453482
  • Legal Action Center [webpage on the Internet]Legality of Denying Access to Medication Assisted Treatment in the Criminal Justice System2011 Available from: http://lac.org/wp-content/uploads/2014/12/MAT_Report_FINAL_12-1-2011.pdfAccessed October 14, 2015
  • SmoyerABBlankenshipKMBeltBCompensation for incarcerated research participants: diverse state policies suggest a new research agendaAm J Public Health200999101746175219696389